| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.001 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.002 |